Previous Article | Next Article 
Infection and Immunity, March 1999, p. 1100-1106, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Transcutaneous Immunization with Bacterial
ADP-Ribosylating Exotoxins as Antigens and Adjuvants
Gregory M.
Glenn,1,2,*
Tanya
Scharton-Kersten,1,2
Russell
Vassell,1,2
Gary R.
Matyas,1 and
Carl R.
Alving1
Department of Membrane Biochemistry, Walter
Reed Army Institute of Research, Washington, D.C.
20307-5100,1 and IOMAI Corp.,
Washington, D.C. 200372
Received 1 September 1998/Returned for modification 14 October
1998/Accepted 30 November 1998
Transcutaneous immunization (TCI) is a new technique that uses the
application of vaccine antigens in a solution on the skin to
induce potent antibody responses without systemic or local toxicity. We
have previously shown that cholera toxin (CT), a potent adjuvant for
oral and nasal immunization, can induce both serum and mucosal
immunoglobulin G (IgG) and IgA and protect against toxin-mediated
mucosal disease when administered by the transcutaneous route.
Additionally, CT acts as an adjuvant for coadministered antigens such
as tetanus and diphtheria toxoids when applied to the skin. CT, a
member of the bacterial ADP-ribosylating exotoxin (bARE)
family, is most potent as an adjuvant when the A-B subunits are present
and functional. We now show that TCI induces secondary antibody
responses to coadministered antigens as well as to CT in
response to boosting immunizations. IgG antibodies to
coadministered antigens were also found in the stools and lung washes
of immunized mice, suggesting that TCI may target mucosal pathogens.
Mice immunized by the transcutaneous route with tetanus fragment C and
CT developed anti-tetanus toxoid antibodies and were protected against
systemic tetanus toxin challenge. We also show that bAREs, similarly
organized as A-B subunits, as well as the B subunit of CT alone,
induced antibody responses to themselves when given via TCI. Thus, TCI appears to induce potent, protective immune responses to both systemic
and mucosal challenge and offers significant potential practical
advantages for vaccine delivery.
*
Corresponding author. Mailing address: Department
of Membrane Biochemistry, Walter Reed Army Institute of Research, Bldg. 40, Rm. 3049, 14th and Dahlia Sts. NW, Washington, DC 20307-5100. Phone: (202) 782-3137. Fax: (202) 782-1890. E-mail:
gglenn{at}iomai.com.
Infection and Immunity, March 1999, p. 1100-1106, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zhu, C., Yu, J., Yang, Z., Davis, K., Rios, H., Wang, B., Glenn, G., Boedeker, E. C.
(2008). Protection against Shiga Toxin-Producing Escherichia coli Infection by Transcutaneous Immunization with Shiga Toxin Subunit B. CVI
15: 359-366
[Abstract]
[Full Text]
-
Ghose, C., Kalsy, A., Sheikh, A., Rollenhagen, J., John, M., Young, J., Rollins, S. M., Qadri, F., Calderwood, S. B., Kelly, C. P., Ryan, E. T.
(2007). Transcutaneous Immunization with Clostridium difficile Toxoid A Induces Systemic and Mucosal Immune Responses and Toxin A-Neutralizing Antibodies in Mice. Infect. Immun.
75: 2826-2832
[Abstract]
[Full Text]
-
Rollenhagen, J. E., Kalsy, A., Cerda, F., John, M., Harris, J. B., LaRocque, R. C., Qadri, F., Calderwood, S. B., Taylor, R. K., Ryan, E. T.
(2006). Transcutaneous Immunization with Toxin-Coregulated Pilin A Induces Protective Immunity against Vibrio cholerae O1 El Tor Challenge in Mice.. Infect. Immun.
74: 5834-5839
[Abstract]
[Full Text]
-
Zhang, J., Shi, Z., Kong, F.-k., Jex, E., Huang, Z., Watt, J. M., Van Kampen, K. R., Tang, D.-c. C.
(2006). Topical Application of Escherichia coli-Vectored Vaccine as a Simple Method for Eliciting Protective Immunity.. Infect. Immun.
74: 3607-3617
[Abstract]
[Full Text]
-
Guebre-Xabier, M., Hammond, S. A., Ellingsworth, L. R., Glenn, G. M.
(2004). Immunostimulant Patch Enhances Immune Responses to Influenza Virus Vaccine in Aged Mice. J. Virol.
78: 7610-7618
[Abstract]
[Full Text]
-
Berry, L. J., Hickey, D. K., Skelding, K. A., Bao, S., Rendina, A. M., Hansbro, P. M., Gockel, C. M., Beagley, K. W.
(2004). Transcutaneous Immunization with Combined Cholera Toxin and CpG Adjuvant Protects against Chlamydia muridarum Genital Tract Infection. Infect. Immun.
72: 1019-1028
[Abstract]
[Full Text]
-
Riminton, D. S., Kandasamy, R., Dravec, D., Basten, A., Baxter, A. G.
(2004). Dermal Enhancement: Bacterial Products on Intact Skin Induce and Augment Organ-Specific Autoimmune Disease. J. Immunol.
172: 302-309
[Abstract]
[Full Text]
-
Anjuere, F., George-Chandy, A., Audant, F., Rousseau, D., Holmgren, J., Czerkinsky, C.
(2003). Transcutaneous Immunization with Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses Via Selective Induction of Th1 Immune Responses. J. Immunol.
170: 1586-1592
[Abstract]
[Full Text]
-
Beignon, A.-S., Briand, J.-P., Rappuoli, R., Muller, S., Partidos, C. D.
(2002). The LTR72 Mutant of Heat-Labile Enterotoxin of Escherichia coli Enhances the Ability of Peptide Antigens To Elicit CD4+ T Cells and Secrete Gamma Interferon after Coapplication onto Bare Skin. Infect. Immun.
70: 3012-3019
[Abstract]
[Full Text]
-
Poland, G. A, Murray, D., Bonilla-Guerrero, R.
(2002). Science, medicine, and the future: New vaccine development. BMJ
324: 1315-1319
[Full Text]
-
Guerena-Burgueno, F., Hall, E. R., Taylor, D. N., Cassels, F. J., Scott, D. A., Wolf, M. K., Roberts, Z. J., Nesterova, G. V., Alving, C. R., Glenn, G. M.
(2002). Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli Vaccine Administered Transcutaneously. Infect. Immun.
70: 1874-1880
[Abstract]
[Full Text]
-
Arrington, J., Braun, R. P., Dong, L., Fuller, D. H., Macklin, M. D., Umlauf, S. W., Wagner, S. J., Wu, M. S., Payne, L. G., Haynes, J. R.
(2002). Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin from Escherichia coli Are Strong Adjuvants for DNA Vaccines. J. Virol.
76: 4536-4546
[Abstract]
[Full Text]
-
Yu, J., Cassels, F., Scharton-Kersten, T., Hammond, S. A., Hartman, A., Angov, E., Corthesy, B., Alving, C., Glenn, G.
(2002). Transcutaneous Immunization Using Colonization Factor and Heat-Labile Enterotoxin Induces Correlates of Protective Immunity for Enterotoxigenic Escherichia coli. Infect. Immun.
70: 1056-1068
[Abstract]
[Full Text]
-
Shi, Z., Zeng, M., Yang, G., Siegel, F., Cain, L. J., van Kampen, K. R., Elmets, C. A., Tang, D.-C. C.
(2001). Protection against Tetanus by Needle-Free Inoculation of Adenovirus-Vectored Nasal and Epicutaneous Vaccines. J. Virol.
75: 11474-11482
[Abstract]
[Full Text]
-
Chen, D., Periwal, S. B., Larrivee, K., Zuleger, C., Erickson, C. A., Endres, R. L., Payne, L. G.
(2001). Serum and Mucosal Immune Responses to an Inactivated Influenza Virus Vaccine Induced by Epidermal Powder Immunization. J. Virol.
75: 7956-7965
[Abstract]
[Full Text]
-
Scharton-Kersten, T., Yu, J.-m., Vassell, R., O'Hagan, D., Alving, C. R., Glenn, G. M.
(2000). Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants. Infect. Immun.
68: 5306-5313
[Abstract]
[Full Text]
-
Weltzin, R., Guy, B., Thomas, W. D. Jr., Giannasca, P. J., Monath, T. P.
(2000). Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pylori Infection. Infect. Immun.
68: 2775-2782
[Abstract]
[Full Text]